An Liu

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a multicenter retrospective study.

Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a multicenter retrospective study.

Journal: Frontiers in medicine

Published: December 03, 2025

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study.

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study.

Journal: Open forum infectious diseases

Published: November 12, 2025

Higher Baseline Triglyceride-Glucose Index Is Inversely Associated With Incomplete Immune Reconstitution in HIV: A Multicentre Cohort Study.

Higher Baseline Triglyceride-Glucose Index Is Inversely Associated With Incomplete Immune Reconstitution in HIV: A Multicentre Cohort Study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 07, 2025

Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China.

Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China.

Journal: Frontiers in medicine

Published: February 12, 2025

A novel HIV-1 circulating recombinant form (CRF168_0107) identified from men who have sex with men in Beijing, China.

A novel HIV-1 circulating recombinant form (CRF168_0107) identified from men who have sex with men in Beijing, China.

Journal: The Journal of infection

Published: November 16, 2024

HIV Pre-Exposure Prophylaxis Cascade Stages Among Men Who Have Sex With Men With Sexually Transmitted Infections in China: Multicenter Cross-Sectional Survey Study.

HIV Pre-Exposure Prophylaxis Cascade Stages Among Men Who Have Sex With Men With Sexually Transmitted Infections in China: Multicenter Cross-Sectional Survey Study.

Journal: JMIR public health and surveillance

Published: August 24, 2024

Effectiveness of onsite and online education in enhancing knowledge and use of human immunodeficiency virus pre- and post-exposure prophylaxis.

Effectiveness of onsite and online education in enhancing knowledge and use of human immunodeficiency virus pre- and post-exposure prophylaxis.

Journal: World journal of clinical cases

Published: January 30, 2024

Related barriers to using HIV pre-exposure prophylaxis among MSM: A multicentre cross-sectional survey.

Related barriers to using HIV pre-exposure prophylaxis among MSM: A multicentre cross-sectional survey.

Journal: HIV medicine

Published: October 09, 2023

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.

Journal: The Lancet regional health. Western Pacific

Published: December 02, 2022

Clinical characteristics, diagnosis, and predictors of neurosyphilis patients with human immunodeficiency virus co-infection: A retrospective study at infectious diseases hospitals in two cities of China.

Clinical characteristics, diagnosis, and predictors of neurosyphilis patients with human immunodeficiency virus co-infection: A retrospective study at infectious diseases hospitals in two cities of China.

Journal: Medicine

Published: February 17, 2021

Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China.

Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China.

Journal: BMC public health

Published: November 17, 2020

Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study.

Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study.

Journal: Frontiers in psychiatry

Published: July 02, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026